Mergon Group has completed its acquisition of Inmo Tech, an Enniscrone, Co Sligo manufacturer of precision injection-moulded components, giving healthcare and medical device customers a larger Irish moulding base within an engineering-led group as consolidation reshapes the specialist components supply chain.

The acquisition is Mergon's second bolt-on since private equity firm Elysian Capital invested, following the earlier purchase of Mergon UK, and gives the Enniscrone operation access to the group's engineering, automation, product development and project management capabilities.

Inmo Tech, incorporated in 1985, operates a 30,000 sq ft plant in Enniscrone running 24 hours a day, with more than 20 injection moulding machines, 14 robots and class 100,000 cleanroom moulding, serving healthcare, electrical, building and domestic appliance customers.

Mergon Group, headquartered in Castlepollard, Co Westmeath, is an engineering-led manufacturer with operations in Ireland, the US, the Czech Republic, the UK and Mexico, supplying healthcare customers including Abbott, Beckman Coulter and Pfizer; Elysian Capital is its private equity backer.

Stéphane Maravel, CEO of Mergon Group, said Inmo Tech has built a strong reputation for specialist healthcare moulding, supported by deep technical knowledge and a committed team, and described the business as a strategic fit. Brendan Cunningham, general manager of Inmo Tech, said joining Mergon opens a new chapter, with the group's scale, resources and international experience supporting continued development.

The deal reflects private equity-backed buy-and-build consolidation in precision moulding, where healthcare qualification, cleanroom capacity and customer approvals make established sites more valuable to acquirers than greenfield builds.

The timing tracks steady demand for medical-grade moulding, with the global medical injection moulding market forecast to grow from $25.3bn in 2025 to $35.8bn by 2034, a 3.83 per cent compound annual rate.

For the sector, Mergon's second bolt-on in this phase shows regional healthcare moulders with cleanroom capacity and long-standing customer approvals becoming priority targets for engineering-led groups seeking scale in a specialised, quality-driven market.

The wider signal for the sector is that Irish healthcare manufacturing is consolidating around groups able to pair moulding capacity with automation and project management, rather than smaller standalone moulders operating alone.

Source: Mergon Group / Westmeath Examiner / Elysian Capital / IMARC Group